Trial intelligence / Profile preview

Islet Transplantation in Type 1 Diabetes (Edmonton Protocol)

NCT00133809Phase 2Completed

Sponsor
Emory University
Start
Jul 2002
Primary completion
Dec 2014
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of donislecel in type 1 diabetes mellitus (T1D), sponsored by Emory University. Started Jul 2002; status: completed.

02

Drugs

donislecel
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00133809.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00133809.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call